Navigation Links
Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution
Date:4/25/2008

ia's largest pharmaceutical company. Ohm is engaged in the sale and distribution of generic and branded private label, OTC products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.

*Children's Zyrtec(R) Oral Solution is a registered trademark of McNeil Consumer Healthcare.

CONTACTS: Charles M. Caprariello

Vice President, Corporate Communications

Ranbaxy Inc.

(609) 720-5615

Edwige Buteau

RF Binder Partners Inc.

(212) 994-7517

Caroline Mozingo

RF Binder Partners Inc.

(212) 994-7560


'/>"/>
SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
2. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
3. Ranbaxy Receives Tentative Approval For Valsartan Tablets
4. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
5. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Michael E. DeBakey Receives Congressional Gold Medal
8. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
9. Cadient Group Receives Multiple Awards at 2008 DTC National Advertising Awards
10. The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA)
11. PainCare Receives Notices From American Stock Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
(Date:7/6/2015)... Oakland, CA (PRWEB) , ... July 06, 2015 , ... ... Adults can learn how to reduce their risk of having a fracture through the ... Freedom From Fractures Awareness Day. , “We are participating because our residents need this ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud hosting ... Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading talent ... future call center platform. , Promero will implement and manage the private ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... for Dental Research (IADR) is presenting its 2009 Oral ... the University of California, Los Angeles (UCLA), USA. The ... & Exhibition in Miami, Florida, USA, April 1, 2009. ... Beijing, China, in 1989, and a Ph.D. in genetics ...
... Conference March 19th at 10 a.m. in Falls Church ... Connolly, several prominent doctors from Inova Health System and public ... March 19th in Falls Church to call for quick passage ... Drug Administration (FDA) authority over tobacco products. The House ...
... About the High Cost of Preterm Birth , at U.S. ... medical costs that businesses pay to care for one premature ... a dozen healthy, full-term births, according to new statistics from ... medical cost for healthy full-term babies from birth through their ...
... Providing More Specific Guidance to Maximize Appropriate Aspirin Use ... Task Force (USPSTF) today strongly recommends that patients and ... heart attack and stroke, while considering benefits and risks. ... Annals of Internal Medicine , build on the ...
... Evaluation and Research (CDER), industry, and academia will convene at the ... 26-29; Arlington, VA) to discuss statistical methodologies and quantitative approaches in ... ... Horsham, PA (Vocus) March 17, 2009 -- Speakers from ...
... 17 The Health Resources and Services Administration (HRSA) ... of ways to prevent poisonings across the United States.HRSA ... Poison Prevention Week Planner March 17 at the ... National Poison Prevention Week, March 15-21. The downloadable ...
Cached Medicine News:Health News:U.S. Rep. Connolly, Inova Hospital Physicians, Public Health Groups Call for Congressional Action to Protect Kids From Tobacco 2Health News:Medical Costs for One Premature Baby Could Cover a Dozen Healthy Births 2Health News:Medical Costs for One Premature Baby Could Cover a Dozen Healthy Births 3Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 2Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 3Health News:U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke 4Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:HRSA Launches Online Resource to Help Prevent Poisonings 2
(Date:7/6/2015)... PARK, Calif. , July 6, 2015  Protiviti, ... its 2015 Internal Auditing around the World ... Protiviti has analyzed and reported on the evolution of ... companies from around the globe as a means to ... deeper understanding of this strategic business function. ...
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... BOULDER, Colo. , July 6, 2015 /PRNewswire/ ... inhibitor, encorafenib, was showcased this past weekend at ... during an oral presentation.  At the meeting, data ... preliminary data from a 100-patient randomized Phase 2 ... encorafenib and cetuximab, an EGFR inhibitor, with or ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... (Nasdaq: BIOD ) announced today that it will be ... JMP Securities Healthcare Conference, September 28, 2010 at 12:00 pm Eastern ... Interested parties can access a link to the live webcast of ... website www.biodel.com . Replays of the presentation will be available ...
... today announced that six-month follow-up clinical trial data ... the company,s Genous Bio-engineered R stent in combination ... de novo coronary artery disease. The data were ... Germany, principal investigator of the study, in the ...
Cached Medicine Technology:OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 2OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 3
... The HAAG-STREIT OM 900 Ophthalmometer uses a ... three requirements of Helmholtz: 1. The size ... the distance between the Ophthalmometer and the ... independent of the distance between the Ophthalmometer ...
... complete image capture and management application that ... leading ophthalmic clinicians, ophthalmic photographers and optometrists ... securely document the eye via the slit ... slit lamps equipped with digital or video ...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
Medicine Products: